 |
|
|
| |
HIGH SVR RATES WITH ABT-493 + ABT-530 CO-ADMINISTERED FOR 8 WEEKS
IN NON-CIRRHOTIC PATIENTS WITH HCV GENOTYPE 3 INFECTION
|
| |
| |
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
Andrew J Muir1, Simone Strasser2, Stanley Wang3, Stephen Shafran4, Maurizio Bonacini5, Paul Y Kwo6, David L Wyles7, Edward Gane8,
Sandra S Lovell3, Chih-Wei Lin3, Teresa I Ng3, Jens Kort3, Federico J Mensa3
1Duke University School of Medicine, Durham, NC, USA; 2AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Camperdown NSW, Australia; 3AbbVie Inc., North Chicago, Illinois, United States; 4University of Alberta Hospital, Edmonton, AB, Canada; 5California Pacific Medical Center, San Francisco, CA, USA; 6Indiana University School of Medicine, Indianapolis, IN, USA; 7University of California San Diego, La Jolla, CA, USA; 8University of Auckland, Auckland, New Zealand
|
| |
|
|
|
|
|
